IBUPROFEN ALONE & IN COMBINATION WITH ACETAMINOPHEN FOR FEVER

单独布洛芬

• 批准号: 7625782
• 负责人: IAN A. PAUL
• 金额: $ 0.29万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625782
• 关键词: Acetaminophen; Computer Retrieval of Information on Scientific Projects Database; Dose; Fever; Funding; Grant; Hour; Ibuprofen; Institution; Research; Research Personnel; Resources; Schedule; Source; Treatment Protocols; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The investigators hypothesize that combination and alternating regimens of acetaminophen and ibuprofen will be superior to ibuprofen alone for antipyresis in a single six-hour dosing schedule.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 中心，不一定是研究者的机构。 研究人员推测，在六小时的单一给药方案中，对乙酰氨基酚和布洛芬的联合和交替治疗方案将优于单独使用布洛芬的退烧方案。